| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000273065.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001871373 |
Sensitive |
| ENSG00000273065.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.04882937 |
Resistant |
| ENSG00000273065.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004801438 |
Sensitive |
